Form 4: Clover Health Interim CFO Reports RSU Tax Withholding

Interim CFO Joseph Clay Thornton reported the withholding of 4,158 shares of Class A Common Stock to satisfy tax obligations related to RSU vesting.

Summary

• Interim CFO Joseph Clay Thornton disposed of 4,158 shares of Class A Common Stock on April 15, 2026.
• The transaction was an automatic withholding of shares to cover tax liabilities associated with the vesting of restricted stock units (RSUs).
• The RSUs were originally granted on October 15, 2024, and vest in quarterly installments of 6.25%.
• Following this transaction, the reporting person maintains a direct beneficial ownership of 1,234,526 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is a routine administrative tax withholding related to pre-existing equity compensation plans.

Positives

• The transaction reflects the ongoing vesting of equity compensation, aligning the executive's interests with long-term shareholder value.

Negatives

• The transaction represents a reduction in the direct share count held by the Interim CFO, albeit for tax purposes.

Risks

• Continued service is required for the remaining unvested RSUs to vest through the final date of October 15, 2028.

Future Outlook

The remaining RSUs are scheduled to vest in equal quarterly installments of 6.25% until the final vesting date on October 15, 2028, contingent upon the reporting person's continued service.

Management Comments

• The transaction was an automatic withholding to cover tax obligations upon the vesting of equity awards.

Industry Context

StockSavvy.ai notes that automatic tax withholding transactions are standard administrative procedures for executives and do not typically signal a change in management sentiment regarding the company's outlook.

Comparison to Industry Standards

• The use of automatic share withholding for tax obligations is a standard practice among U.S. public companies for managing executive equity compensation.
• The vesting schedule of four years is consistent with typical long-term incentive plans for executive officers in the healthcare technology sector.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a routine tax-related share withholding.

Next Steps

• Continued quarterly vesting of remaining RSUs through October 15, 2028.

Key Dates

Keywords

Clover Health, CLOV, Insider Trading, Form 4, Executive Compensation, RSU Vesting